These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35360021)

  • 1. Comorbidity of Type 2 Diabetes Mellitus and Depression: Clinical Evidence and Rationale for the Exacerbation of Cardiovascular Disease.
    Zhu M; Li Y; Luo B; Cui J; Liu Y; Liu Y
    Front Cardiovasc Med; 2022; 9():861110. PubMed ID: 35360021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antidiabetic drugs on the incidence of macrovascular complications and mortality in type 2 diabetes mellitus: a new perspective on sodium-glucose co-transporter 2 inhibitors.
    Rahelić D; Javor E; Lucijanić T; Skelin M
    Ann Med; 2017 Feb; 49(1):51-62. PubMed ID: 27535028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association.
    Arnold SV; Bhatt DL; Barsness GW; Beatty AL; Deedwania PC; Inzucchi SE; Kosiborod M; Leiter LA; Lipska KJ; Newman JD; Welty FK;
    Circulation; 2020 May; 141(19):e779-e806. PubMed ID: 32279539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.
    Yandrapalli S; Jolly G; Horblitt A; Sanaani A; Aronow WS
    Postgrad Med; 2017 Nov; 129(8):811-821. PubMed ID: 28749197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus.
    Schernthaner G; Schernthaner-Reiter MH; Schernthaner GH
    Clin Ther; 2016 Jun; 38(6):1288-1298. PubMed ID: 27210264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrovascular Complications of Type 2 Diabetes Mellitus.
    Viigimaa M; Sachinidis A; Toumpourleka M; Koutsampasopoulos K; Alliksoo S; Titma T
    Curr Vasc Pharmacol; 2020; 18(2):110-116. PubMed ID: 30961498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus.
    Li T; Providencia R; Mu N; Yin Y; Chen M; Wang Y; Liu M; Yu L; Gu C; Ma H
    Cardiovasc Diabetol; 2021 Jan; 20(1):30. PubMed ID: 33516224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Depression, Antidepression Medications, and the Risk of Developing Type 2 Diabetes Mellitus: A Nationwide Population-Based Retrospective Cohort Study in Taiwan.
    Fang YJ; Wu TY; Lai JN; Lin CL; Tien N; Lim YP
    Biomed Res Int; 2021; 2021():8857230. PubMed ID: 33506043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs.
    Karki R; Kodamullil AT; Hofmann-Apitius M
    J Alzheimers Dis; 2017; 60(2):721-731. PubMed ID: 28922161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Night-time heart rate variability identifies high-risk people among people with uncomplicated type 2 diabetes mellitus.
    Hadad R; Larsen BS; Weber P; Stavnem D; Kristiansen OP; Nielsen OW; Haugaard SB; Sajadieh A
    Diabet Med; 2021 Jul; 38(7):e14559. PubMed ID: 33714218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidities and complications in Japanese patients with type 2 diabetes mellitus: Retrospective analyses of J-DREAMS, an advanced electronic medical records database.
    Ohsugi M; Eiki JI; Iglay K; Tetsuka J; Tokita S; Ueki K
    Diabetes Res Clin Pract; 2021 Aug; 178():108845. PubMed ID: 33933501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes, hypertension, and cardiovascular disease development.
    Yen FS; Wei JC; Chiu LT; Hsu CC; Hwu CM
    J Transl Med; 2022 Jan; 20(1):9. PubMed ID: 34980154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 Diabetes and Myocardial Infarction: Recent Clinical Evidence and Perspective.
    Cui J; Liu Y; Li Y; Xu F; Liu Y
    Front Cardiovasc Med; 2021; 8():644189. PubMed ID: 33718461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease.
    Sprenger L; Mader A; Larcher B; Mächler M; Vonbank A; Zanolin-Purin D; Leiherer A; Muendlein A; Drexel H; Saely CH
    BMJ Open Diabetes Res Care; 2021 Nov; 9(2):. PubMed ID: 34782334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes.
    Paneni F; Lüscher TF
    Am J Med; 2017 Jun; 130(6S):S18-S29. PubMed ID: 28526186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data.
    Sposito AC; Berwanger O; de Carvalho LSF; Saraiva JFK
    Cardiovasc Diabetol; 2018 Dec; 17(1):157. PubMed ID: 30545359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Strategy for Type 2 Diabetes with Obesity: Focus on Glucagon-like Peptide-1 Receptor Agonists.
    Ji Q
    Clin Ther; 2017 Jun; 39(6):1244-1264. PubMed ID: 28526416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular prevention in type 2 diabetic patients: review of efficacious treatments.
    Goderis G; Boland B
    Acta Clin Belg; 2004; 59(6):329-39. PubMed ID: 15819377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.